Glycometrix, Inc. is an emerging life sciences company dedicated to improving the quality of patient care by providing physicians a clinically reliable cost effective method of detecting, diagnosing and monitoring complex disease states using an analysis of cell glycosylation.

As cells become diseased, their glycosylation, or carbohydrate outer layer, is altered, thus effecting how the cells interact with their surroundings. Using this information Glycometrix is developing a novel and reliable method of detecting disease in patients using only a small amount of blood serum. This proprietary technology has broad implications for detecting disease long before symptoms occur and for improving patient treatment options.